A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
Clinical trial NCT04598477 · TERMINATED
Trial details
- NCT number
- NCT04598477
- Sponsor
- argenx
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2024-03-25
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.